(no text — see the shared post below)

SATURN: high-dose statins reversed plaque 1-2%; each 1% PAV cut means 20% fewer events
Louis highlights the SATURN trial, where high-dose statins reversed plaque by about 1-2% PAV over two years, and each 1% PAV reversal is associated with about 20% fewer MACE. A shared meta-analysis of 31 studies and 4,997 patients (Li 2021) found lipid-lowering lowered TAV and PAV on IVUS.


